Drug Markets/Eletriptan Hydrobromide

Eletriptan Hydrobromide

16 NDCs across 7 manufacturers|11 Generic,5 Brand

Eletriptan Hydrobromide is used to treat migraine disorders, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on Dec 26, 2002, and the first generic was approved Jun 16, 2017. FDA's Orange Book lists 16 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $9 million on Eletriptan Hydrobromide across 70,000 claims for 17,000 beneficiaries.

Eletriptan Hydrobromide is available as 16 NDCs from 7 manufacturers (11 generic, 5 brand), with NADAC prices from $1.78 to $77.43 per EA — the most expensive product costs about 44× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

16

11G / 5B

Manufacturers

7

competing in market

Price Spread

$1.78 – $77.43

per EA

7d Activity

13↑3 flat

avg +6.7% WoW · of 16 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Drug Portfolio

16 NDCs total, 16 shown

WatchDrug ↕Price 7d Change ↕
RELPAX 20 MG TABLET
$77.4338
per EA
—
RELPAX 20 MG TABLET
$77.3731
per EA
—
RELPAX 40 MG TABLET
$77.2066
per EA
+0.17%
RELPAX 40 MG TABLET
$77.2066
per EA
+0.17%
RELPAX 40 MG TABLET
$77.1444
per EA
—
ELETRIPTAN HBR 40 MG TABLET
$1.8391
per EA
+4.36%
ELETRIPTAN HBR 40 MG TABLET
$1.8391
per EA
+4.36%
ELETRIPTAN HBR 40 MG TABLET
$1.8391
per EA
+4.36%
ELETRIPTAN HBR 40 MG TABLET
$1.8391
per EA
+4.36%
ELETRIPTAN HBR 40 MG TABLET
$1.8391
per EA
+4.36%
ELETRIPTAN HBR 40 MG TABLET
$1.8391
per EA
+4.36%
ELETRIPTAN HBR 20 MG TABLET
$1.7799
per EA
+12.01%
ELETRIPTAN HBR 20 MG TABLET
$1.7799
per EA
+12.01%
ELETRIPTAN HBR 20 MG TABLET
$1.7799
per EA
+12.01%
ELETRIPTAN HBR 20 MG TABLET
$1.7799
per EA
+12.01%
ELETRIPTAN HBR 20 MG TABLET
$1.7799
per EA
+12.01%

Frequently Asked Questions

What is Eletriptan Hydrobromide used to treat?

Eletriptan Hydrobromide is used to treat migraine disorders, per the National Library of Medicine's MED-RT classification.

When did Eletriptan Hydrobromide become available as a generic?

FDA approved the first generic Eletriptan Hydrobromide (ANDA) on Jun 16, 2017. The Orange Book currently lists 16 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How much does Medicare spend on Eletriptan Hydrobromide?

In 2024, Medicare Part D spent $9 million on Eletriptan Hydrobromide across 70,000 claims for 17,000 beneficiaries.

How many Eletriptan Hydrobromide products are on the market?

The Eletriptan Hydrobromide drug market contains 16 NDCs from 7 manufacturers — 11 generic and 5 brand products.

What is the price range for Eletriptan Hydrobromide?

NADAC reference prices for Eletriptan Hydrobromide range from $1.7799 to $77.4338 per EA — the most expensive product costs about 44× the cheapest.

Is generic Eletriptan Hydrobromide cheaper than brand?

The average generic NADAC for Eletriptan Hydrobromide is $1.8122 per EA, versus $77.2729 for brand-labeled products — brand versions average about 43× the generic price.

Which manufacturers make Eletriptan Hydrobromide?

7 manufacturers list Eletriptan Hydrobromide in NADAC. Ranked by number of NDCs, the largest are Viatris Specialty LLC (3), Mylan Pharmaceuticals Inc. (3), Roerig (2), Camber Pharmaceuticals Inc. (2), Teva Pharmaceuticals USA Inc. (2).

How has the price of Eletriptan Hydrobromide changed recently?

Over the past 7 days, 13 Eletriptan Hydrobromide NDCs rose and 0 fell, with a market-wide average change of +6.7%.